PureTech Health (NASDAQ:PRTC) Shares Down 4.2% - What's Next?

PureTech Health plc (NASDAQ:PRTC - Get Free Report)'s share price traded down 4.2% during mid-day trading on Monday . The stock traded as low as $17.83 and last traded at $18.20. 1,376 shares were traded during trading, a decline of 71% from the average session volume of 4,708 shares. The stock had previously closed at $19.00.

PureTech Health Stock Performance

The company's 50-day simple moving average is $17.25 and its 200-day simple moving average is $18.61.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Birch Hill Investment Advisors LLC acquired a new position in shares of PureTech Health during the fourth quarter worth about $5,575,000. Millennium Management LLC acquired a new position in shares of PureTech Health during the fourth quarter worth about $823,000. Finally, Pentwater Capital Management LP increased its stake in shares of PureTech Health by 39.2% during the first quarter. Pentwater Capital Management LP now owns 33,560 shares of the company's stock worth $664,000 after acquiring an additional 9,449 shares during the period. 0.04% of the stock is owned by hedge funds and other institutional investors.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.